Urinary incontinence Fecal incontinence
Conditions
Interventions
Transvaginal and/or transanal high-intensity focused ultrasound (HIFU) therapy performed as a single-session treatment.
Sponsors
Suzuki Proctology-Moriguchi Internal Medicine Clinic
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: - Patients with urinary incontinence, fecal incontinence. - Patients who underwent transvaginal or transanal high-intensity focused ultrasound (HIFU) treatment. - Patients with available clinical evaluations before and after treatment. - Patients for whom comprehensive consent, including opt-out consent, was obtained.
Exclusion criteria
Exclusion criteria: - Patients with symptoms attributable to causes other than urinary incontinence, fecal incontinence. - Patients with insufficient clinical data for evaluation. - Patients without available clinical assessments before and after treatment. - Patients with severe comorbidities or general conditions that made evaluation difficult. - Patients for whom comprehensive consent, including opt-out consent, was not obtained.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in the severity of urinary and fecal incontinence symptoms assessed by the ICIQ-SF score and Wexner score before treatment and within 3 months after treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Time to symptom improvement based on patient-reported outcomes. - Comparison of treatment effects according to incontinence subtype (stress, urge, and mixed). - Changes in anorectal manometric parameters, including maximum resting pressure and maximum squeeze pressure, before treatment and approximately 2 months after treatment. - Re-treatment rate and recurrence during the follow-up period. | — |
Countries
Japan
Contacts
Public ContactShunsuke Suzuki
Suzuki Proctology-Moriguchi Internal Medicine Clinic Suzuki Proctology-Moriguchi Internal Medicine Clinic
Outcome results
None listed